載入...
Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice
Icosabutate is a structurally engineered eicosapentaenoic acid derivative under development for nonalcoholic steatohepatitis (NASH). In this study, we investigated the absorption and distribution properties of icosabutate in relation to liver targeting and used rodents to evaluate the effects of ico...
Na minha lista:
| 發表在: | Hepatol Commun |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6996349/ https://ncbi.nlm.nih.gov/pubmed/32025605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1453 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|